The 2nd International Conference on Pharmaceuticals and New Trends in Drug Discovery
The 2nd International Conference on Pharmaceuticals and New Trends in Drug Discovery
Part of the International Conference on Pharmaceuticals series
15 January 2027
19 February 2027
26 February 2027
5 March 2027
28 April 2027
Medicinal Chemistry, Natural Products, Biopharmaceuticals, Antimicrobials, Oncology Therapeutics, AI and Drug Discovery
Security Notice
Please note that all official conference emails will be sent exclusively from the @mdpi.com and info@sciforum.com domain. Please do not respond to any suspicious emails or share personal or financial information through unverified channels.
The ICOPharm-2 is Now OPEN for Abstract Submission and Registration.
Instructions for authors are available online.
Submit your abstracts HERE.
For any inquiries, please contact us at icopharm@mdpi.com.
Welcome from the Chairs
We are delighted to announce the 2nd International Conference on Pharmaceuticals and New Trends in Drug Discovery, to be held in Lisbon, Portugal, from 11 to 14 May 2027.
This conference is organized by MDPI’s open-access journal Pharmaceuticals (ISSN 1424-8247, IF: 5.7) and will bring together leading researchers, scientists, and professionals from academia and industry to discuss the latest developments, challenges, and opportunities in pharmaceutical sciences and drug discovery.
This year’s scientific program will cover a broad range of timely and impactful topics, including:
- Synthetic Chemistry and Drug Discovery
- Natural Products and Biopharmaceuticals
- Target Identification and Modes of Action
- Antimicrobial Agents and Strategies to Counter Resistance
- Novel Neurotherapies, Inflammation, and Pain Treatment
- Innovative Oncology Therapeutics and Precision Medicine
The conference will feature plenary and invited lectures, selected oral presentations, and poster sessions, offering participants the opportunity to share their latest research findings and engage in meaningful scientific discussions. These sessions will foster interdisciplinary exchange and highlight emerging trends shaping the future of pharmaceuticals and drug discovery.
Set in the vibrant city of Lisbon, the conference will provide not only a stimulating scientific environment but also an inspiring setting for networking and collaboration. With its rich history, dynamic culture, and welcoming atmosphere, Lisbon offers an ideal backdrop for this international event.
We warmly invite researchers, clinicians, industry professionals, and all those interested in pharmaceutical research and innovation to join us for what promises to be an engaging and impactful conference. Together, let us explore new directions in drug discovery and contribute to the advancement of future therapies.
We look forward to your participation.
Event Chairs
Department of Chemistry and Biochemistry (DQB) and Centre of Structural Chemistry (CQE), Institute of Molecular Sciences, Faculty of Sciences, University of Lisbon, Portugal
Prof. Dr. Amélia Pilar Rauter, a full professor, was the founder of the Portuguese Society of Chemistry Carbohydrate Chemistry Group in 1992, and the founder (2001) and leader of the CQB Carbohydrate Chemistry Group—FCUL, a center of excellence of the ESF network Euroglycoforum (2009–2014), and Executive of its Interest Group Glycochemistry. Presently, she is the leader of the CQE Carbohydrate Chemistry Group. Her scientific interests are mainly within the area of organic and biomolecular chemistry. They cover the design and synthesis of new leads based on carbohydrate structures with new mechanisms of action, as well as the isolation and structure elucidation of active principles from plants/marine resources. This research led to the discovery of lead molecules for diabetes, degenerative diseases (Alzheimer´s and Prion diseases, cancer), and infection. Her research falls within the global objective of developing creative and sustainable chemistry for better health.
School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Ireland
Prof. Dr. Mary Jane Meegan completed her PhD degree in UCD under the direction of Professor Dervilla Donnelly in the area of natural product chemistry and subsequently carried out postdoctoral research at the University Chemical Laboratory, Cambridge University in the research group of Professor Alan Battersby in the area of porphyrin synthesis and biosynthesis. Following further research periods at University College Dubin and CNRS Gif-sur-Yvette, she was appointed as lecturer in Pharmaceutical Chemistry at the School of Pharmacy and Pharmaceutical Sciences in Trinity College Dublin. She has research experience in the School of Pharmacy and Pharmaceutical Sciences, Trinity College in the general area of pharmaceutical and medicinal chemistry, with over 100 peer-reviewed scientific papers covering topics such as design and synthesis of anticancer drugs, drug impurity profiling, synthetic methods for library design and in vitro screening. She has extensive experience in scientific and technical management having led an active research group, has acted as Head of the Department of Pharmaceutical Chemistry and as subject area head of Pharmaceutical Chemistry at the School of Pharmacy. Research collaborations have been established within Trinity College with Dr. Niamh O'Boyle (School of Pharmacy and Pharmaceutical Sciences), Dr D Zisterer, Dr D Fayne in the School of Biochemistry and Immunology and also with many European research centres. She is a member of several International Scientific Societies.
Former Head of the Department of Organic Chemistry, University of Mons-UMONS, Belgium
Dr. Eynde used to serve as the former Head of the Department of Organic Chemistry at the University of Mons, Belgium. He is now the Editor-in-Chief of the Drugs and Drug Candidates MDPI. His research focuses on organic chemistry, medicinal chemistry, and green chemistry. Due to his expertise, he has been recognized as an outstanding reviewer by Green Chemistry and the Royal Society of Chemistry.
Sessions
S2. Natural Products and Biopharmaceuticals
S3. Target Identification and Modes of Action
S4. Antimicrobial Agents and Strategies to Counter Resistance
S5. Novel Neurotherapies, Inflammation, and Pain Treatment
S6. Innovative Oncology Therapeutics and Precision Medicine
Instructions for Authors
Please note that all official conference emails will be sent exclusively from the @mdpi.com and info@scifourm.net domain.
Please do not respond to any suspicious emails or share personal or financial information through unverified channels.
2. The conference will be held fully in person, it is not possible to participate online.
3. Please note that abstract submission and conference registration are two separate processes.
4. Please use your institutional email address for both processes.
1. Deadline for abstract submission: 15 January 2027.
2. Announcement of oral and poster abstract results: 19 February 2027. You will be notified of the acceptance of an oral/poster presentation in a separate email.
3. Covering Author Registration deadline: 5 March 2027.
Please note:
An abstract acceptance email only confirms that your abstract has been accepted. However, the conference chairs decide separately whether your presentation will be oral or a poster, and you will receive another email with the result.
1. Choose a session that is best suited for your research.
2. The abstract structure should include the introduction, methods, results, and conclusions sections of about 200–300 words in length.
3. All abstracts should be submitted and presented in clear, publication-ready English with accurate grammar and spelling.
4. Each registration allows submission of only one abstract. However, an author may be listed on multiple abstracts, provided that each abstract has a different registered presenter.
5. All abstracts accepted for presentation will be collected in a book of abstracts, which will be displayed on the website during the conference. If you do not want your abstract to be included in the book of abstracts, please let us know beforehand.
6. Upon submission, you can select if you wish to be considered for oral or poster presentation (or both). Following assessment by the Chairs and Scientific Committee, you will be notified by 19 February 2027 whether your contribution has been accepted for oral or poster presentation.
7. Please note that, in order to finalize the scientific program in due time, at least one registration by any of the authors, denoted as the Covering Author, is required to cover the presentation and publication of any accepted abstract. Your abstract will be withdrawn if your registration is not complete by this date.
Note: We only accept live presentations, no pre-recorded presentations.
Each presentation should:
- Communicate the research question or objective, methodology, key results, and scientific novelty;
- Use a clear and logical structure, typically the Introduction–Methods–Results and Discussion structure (IMRaD) or a field-appropriate alternative;
- Emphasize the relevance of the work;
- Support key findings with clear figures or tables where appropriate;
- Conclude with a critical interpretation of the results and their impact.
Posters will be displayed in portrait orientation on designated poster boards.
• Maximum size: A0 (84 × 120 cm / 33 × 47 in) (in vertical orientation).
• Posters must include: title, authors, affiliations, and contact information.
• Provide a structured overview of the research, including the objective, a concise description of the methodology, the main results supported by clear and well-labeled figures or tables where appropriate, and a brief conclusion highlighting the key findings and their relevance.
• Authors are responsible for printing their posters prior to the conference.
The poster template can be downloaded here.
MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe authors should retain the copyright to their scholarly works. Hence, by submitting an abstract to this conference, you retain the copyright to the work, but you grant MDPI the non-exclusive right to publish this abstract online on the Sciforum.net platform. This means you can easily submit your full paper (with the abstract) to any scientific journal at a later stage and transfer the copyright to its publisher if required.
Any request concerning abstract or proceedings paper withdrawal should be communicated to the Conference Organizing Team as early as possible, preferably prior to final acceptance and confirmation of the conference program. Please note that once abstracts are published in the Conference Report or once Proceedings papers are published in the Proceedings journal and assigned a DOI, they become part of the permanent scholarly record and cannot be fully removed.
The responsible use of generative AI tools in the preparation of abstracts, posters, and presentations is permitted; however, any such use must be clearly disclosed, specifying the tool employed and its role. Authors retain full responsibility for the accuracy and integrity of their work.
Authors must disclose any financial, professional, or personal relationships that could reasonably be perceived as influencing the integrity, interpretation, or presentation of their work. Failure to provide accurate disclosures may result in the removal of the abstract from the conference program and associated publications.
If there is no conflict, please state "The authors declare no conflicts of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Any financial support for the study must be fully disclosed in the "Acknowledgments" section.
In accordance with Swiss copyright law, you, as the author, are the original creator of your work and retain full copyright ownership of your submitted abstract.
License Grant
By submitting your abstract for publication on the Sciforum.net platform, you grant MDPI, the platform’s publisher, a worldwide, royalty-free, non-exclusive license to:
- Publish, reproduce, and distribute the abstract online.
- Make the abstract publicly available in connection with the conference.
Author's Retained Rights
This license is non-exclusive. As you retain full copyright, you are free to:
- Reuse, republish, and build upon your work in any way.
- Develop the abstract into a full paper for submission to other journals or publications.
- Enter into subsequent agreements, including granting an exclusive license or transferring copyright to another publisher for a future version of the work.
Author's Responsibility
You remain solely responsible for complying with the policies of any other journal or publisher to which you may submit a subsequent version of your work, particularly concerning prior publication rules. MDPI and Sciforum.net bear no responsibility for any conflicts arising from your future submissions.
Publication Opportunities
Pharmaceuticals Journal Publication
Participants in this conference are cordially invited to contribute a full manuscript to the conference's Special Issue, published in Pharmaceuticals (ISSN 1424-8247, IF: 4.8), with a 20% discount on the publication fee. Please note if you have IOAP/association discounts, conference discounts will be combined with IOAP/association discounts. Conference discounts cannot be combined with reviewer vouchers. All submitted papers will undergo MDPI’s standard peer-review procedure. The abstracts should be cited and noted on the first page of the paper.
Registration
The conference will be held fully in person; it is not possible to participate online. The registration fee includes attendance at all conference sessions, morning/afternoon coffee breaks, lunches, a conference bag, and a program book. Participation in the conference is considered final only once the registration fees have been paid. The number of participants is limited: once the number of paid registrations reaches the maximum number of participants, unpaid registrations will be canceled.
When registering, please provide us with your institutional email address. This will accelerate the registration process.
If you are registering several people under the same registration order, please do not use the same email address for each person, but their individual institutional email addresses. Thank you for your understanding.
Important Information
Please note that abstract submission and conference registration are two separate processes. During registration, please provide us with the same email address you used to submit your abstract(s). Otherwise, leave us a comment in the registration form, providing the email address used during the submission process. In addition, please use your institutional email address for both processes.
In order to finalize the scientific program in due time, at least one registration by any of the authors, denoted as the covering author, is required to cover the presentation and publication of any accepted abstract. The covering author registration deadline is 5 March 2027. Your abstract will be withdrawn if your registration is not complete by this date.
Certificate of Attendance: Participants of the event will be able to download an electronic Certificate of Attendance by accessing their dashboards on Sciforum.net once the event is concluded. The certificates will be found under the "My Certificates" category.
The fees do not include VAT.
|
Early Bird Until 26 February 2027 |
Regular Until 28 April 2027 |
Supported documents | |
|---|---|---|---|
| Student | 300.00 EUR | 400.00 EUR |
Scanned copy or photograph of your current student ID is required. |
| Academic | 550.00 EUR | 650.00 EUR | |
| Non-academic/Industry | 850.00 EUR | 950.00 EUR | |
| Scientific Committee Members/Pharmaceuticals EBMs | 400.00 EUR | 500.00 EUR |
Cancellation policy
| Cancellation of paid registration is possible under the terms listed below: | |
| > 2 months before the conference | Full refund but 60 EUR is retained for administration |
| > 1 month before the conference | Refund 50% of the applying fees |
| > 2 weeks before the conference | Refund 25% of the applying fees |
| < 2 weeks before the conference | No refund |
Disclaimer
In the unlikely event that MDPI deems it necessary to cancel the conference, all pre-paid registration fees will be reimbursed. MDPI shall not be liable for reimbursing the cost of travel or accommodation arrangements made by individual delegates.
Beware of unauthorized registration and hotel solicitations
Note that Sciforum is the only official registration platform to register to ICOPharm-2 and that we are not associated with any hotel agency. While other hotel resellers and travel agencies may contact you with offers for your trip, they are not endorsed by or affiliated with ICOPharm-2 or Sciforum. Beware that entering into financial agreements with non-endorsed companies can have costly consequences.
Insurance
The organizers do not accept liability for personal accident, loss, or damage to private property incurred as a result of participation in ICOPharm-2. Delegates are advised to arrange appropriate insurance to cover travel, cancellation, or medical costs, and theft or damage of belongings.
MDPI Conference Admissions Policy
- All registered conference delegates are asked to always wear their badges throughout the conference.
- Conference sessions, the catering area, and the poster area are solely restricted to badge holders. Any person attending these areas without a badge will be asked to leave the premises.
- Badge holders must not allow their badges to be worn by anyone else. Any failure to do so is likely to lead to the badge holder and the person wearing the badge being removed from the premises.
- Press badges are restricted to publishers, editors, journalists, broadcasters, and web bloggers associated with the conference subject area. Members of the press may be asked to produce accreditation in the form of a photocopy of a recognized press or media card, a business card, a letter from the editor, or an official web address linking to a press release in order to verify their position.
- Photographs and videos may be taken during the conference. Anyone attending the conference consents to such photography and filming without compensation and confirms that the organizers shall be entitled to use such photographs and videos, which may include photographs and videos of visitors, for the purpose of marketing the conference in the future and for exploitation in any and all media, without liability.
Payment methods
Wire transfer, Credit card
Currencies accepted by this event
Swiss francs (CHF) , Euros (EUR) , US dollars (USD) , Pounds sterling (GBP) , Japanese yen (JPY) , Canadian dollars (CAD) and Singapore dollars (SGD)
Visa Information
Please note that you must apply for your own visa application. MDPI is not responsible for any visa application. However, MDPI can provide a Visa Support Letter. To be eligible for such a document, the criteria below must be fulfilled.
Visa Support Letter
- Applicants must have paid for registration and submitted an abstract in order to get a letter of support.
- Applicants must provide us with a scan of their valid, in-date passport that contains a photo of them.
- Applicants must provide us with a letter of support from their institution to confirm that they support the delegate attending the meeting.
- This must be carried out in good time before the meeting; "last minute" requests will not be processed.
More useful information on visa application
Plan your trip
Event Awards
The Awards
Best Oral Presentation Award and Best Poster Award
The Best Oral Presentation Award certificates are given to the papers judged to make the most significant oral contributions to the conference.
Eligibility: Open to all authors selected as oral speakers who have delivered their presentation.
Criteria: Evaluation based on content quality, delivery clarity, audience interaction, and overall impact.
The Best Poster Award certificates are given to the submissions judged to make the most significant and interesting posters for the conference.
Eligibility: Open to all authors who have presented their work through posters.
Criteria: Evaluation based on scientific merit, creativity, and ability to attract and engage viewers.
Announcement of Winners: The winners of these awards will be announced during the closing ceremony of the conference. We encourage all participants to attend.
Organizers
Sponsors and Partners
As organizers, we are excited to create an immersive and insightful event, and we invite you to be a vital part of ICOPharm-2. Explore our sponsorship opportunities and join us in advancing the future of pharmaceutical sciences, drug discovery, and innovative therapeutic development.
If you have any questions, feel free to contact us via email at icopharm@mdpi.com.
We appreciate your consideration!
For information regarding sponsorship and exhibition opportunities, please click here.
Conference Secretariat
Ms. Dóra Szepesi
Ms. Adelina Platon
Ms. Gabriela Vint
Dr. Alina-Andrada Igna
